Literature DB >> 4352577

Simulation of tissue properties in irreversible diffuse obstructive pulmonary syndromes. Enzyme digestion.

C J Martin, T Sugihara.   

Abstract

The length-tension properties of alveolar wall from normal cats were studied before and after exposure to enzymes naturally found in mammals (elastase, trypsin, collagenase, hyaluronidase). Hyaluronidase effected little change while all the proteolytic enzymes altered the mechanical properties of lung tissue. Collagenase removed the "mechanical stop" and the alveolar walls fractured at low forces. The properties of wall exposed to trypsin resembled those of elastase-treated tissue. Elastase increased the extension necessary to reach a given force and increased the maximum length (L(max)) and resting length (L(o)). Maximum extensibility (lambda(max)), the ratio of L(max) to L(o), fell with both elastase and trypsin digestion. A reduction in lambda(max) simulates the changes in alveolar wall properties seen in the lungs of the aged and in those with an irreversible diffuse obstructive pulmonary syndrome (DOPS(I)). Unlike these states, however, the energy loss in stretching alveolar wall increased with elastolysis. Furthermore, the changes in L(o) necessary to effect a change in lambda(max) of alveolar wall comparable to that seen in DOPS(I) were excessive. The altered tissue properties that occur in man with obstructive pulmonary syndromes could not be produced with these proteolytic enzymes or with hyaluronidase.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352577      PMCID: PMC302473          DOI: 10.1172/JCI107375

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Studies on the collagen and elastin content of the human lung.

Authors:  J A PIERCE; J B HOCOTT
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

2.  Relation of structure to function of the tissues of the wall of blood vessels.

Authors:  A C BURTON
Journal:  Physiol Rev       Date:  1954-10       Impact factor: 37.312

3.  Effects of elastase, collagenase, and papain on structure and function of rat lungs in vitro.

Authors:  W G Johanson; A K Pierce
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

4.  Viscoelastic properties of alveolar wall.

Authors:  T Sugihara; J Hildebrandt; C J Martin
Journal:  J Appl Physiol       Date:  1972-07       Impact factor: 3.531

5.  Lung elastic recoil and airway resistnce as factors limiting forced expiratory flow.

Authors:  R W Penman; R P O'Neill; L Begley
Journal:  Am Rev Respir Dis       Date:  1970-04

6.  Action of proteolytic enzymes on tropocollagen and insoluble collagen.

Authors:  M P Drake; P F Davison; S Bump; F O Schmitt
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

7.  Experimental papain-induced emphysema in dogs.

Authors:  R Pushpakom; J C Hogg; A J Woolcock; A E Angus; P T Macklem; W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1970-11

8.  Elastic behavior of the lung in patients with airway obstruction.

Authors:  K E Finucane; H J Colebatch
Journal:  J Appl Physiol       Date:  1969-03       Impact factor: 3.531

9.  Mechanical properties of the lung in experimental pulmonary emphysema.

Authors:  S S Park; I P Goldring; C S Shim; M H Williams
Journal:  J Appl Physiol       Date:  1969-06       Impact factor: 3.531

10.  Length-tension properties of alveolar wall in man.

Authors:  T Sugihara; C J Martin; J Hildebrandt
Journal:  J Appl Physiol       Date:  1971-06       Impact factor: 3.531

View more
  2 in total

1.  Simulation of lung tissue properties in age and irreversible obstructive syndromes using an aldehyde.

Authors:  T Sugihara; C J Martin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Stimulation of human leukocyte elastase by platelet factor 4. Physiologic, morphologic, and biochemical effects on hamster lungs in vitro.

Authors:  S A Lonky; H Wohl
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.